DavidETrenthamMD
Rheumatology • Boston, MAAssociate Professor of Medicine, Beth Israel Deaconess Medical Center
Are you Dr. Trentham?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 35 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
110 Francis St
Suite 4b
Boston, MA 02215Phone+1 617-632-8658
Summary
- Dr. David Trentham, MD is a rheumatologist in Boston, Massachusetts. He is currently licensed to practice medicine in Massachusetts. He is affiliated with Beth Israel Deaconess Medical Center and is an Associate Professor of Medicine at Beth Israel Deaconess Medical Center.
Education & Training
Brigham and Women's HospitalResidency, Internal Medicine, 1976 - 1978
University of TennesseeResidency, Internal Medicine, 1974 - 1976- University of TennesseeResidency, Internal Medicine, 1970 - 1972
University of Tennessee Health Science Center College of MedicineClass of 1970
Certifications & Licensure
MA State Medical License 1979 - 2023
Awards, Honors, & Recognition
- Elected Member The American Society for Clinical Investigation, 1988
Publications & Presentations
PubMed
- 133 citationsClinical and immunologic effects of fractionated total lymphoid irradiation in refractory rheumatoid arthritis.David E. Trentham, J.A. Belli, Ronald Anderson, J.A. Buckley, E.J. Goetzl
The New England Journal of Medicine. 1981-10-22 - 1239 citationsAutoimmunity to type II collagen an experimental model of arthritis.David E. Trentham, Andrew H. Kang
The Journal of Experimental Medicine. 1977-09-01 - 676 citationsEfficacy of low-dose methotrexate in rheumatoid arthritis.Michael E. Weinblatt, Jonathan S. Coblyn, David A. Fox, Patricia A. Fraser, Donald E. Holdsworth
The New England Journal of Medicine. 1985-03-28
Grant Support
- Core--ChemicalNational Heart, Lung, And Blood Institute2000–2002
- OPEN Label Study Of Oral Type II Collagen In Juvenile Rheumatoid ArthritisNational Center For Research Resources1996–2002
- Therafectin Compared To Placebo In Patients With Rheumatoid ArthritisNational Center For Research Resources1997–2000
- Comparison Of Oral Colloral With Placebo In Active Rheumatoid Arthritis PatientsNational Center For Research Resources1997–2000
- MIRA - Minocycline In Rheumatoid ArthritisNational Institute Of Arthritis And Musculoskeletal And Skin Diseases1991–1993
- Feasibility Study--Characterizing A Lymphokine That Activates RAT Synovial CellsNational Institute Of Arthritis And Musculoskeletal And Skin Diseases1986–1989
- Evaluation Of Tetracyclines In Models Of ArthritisNational Institute Of Arthritis And Musculoskeletal And Skin Diseases1986–1988
- Immunologic Properties Of CollagenNational Institute Of Arthritis And Musculoskeletal And Skin Diseases1985–1987
- Immunologic Properties Of CollagenNat Inst Of Arthritis, Diabetes, Digestive &Kidney Diseases1985
- Feasibility Study--Characterizing A Lymphokine That Activates RAT Synovial CellsNat Inst Of Arthritis, Diabetes, Digestive &Kidney Diseases1985
